Recently, the New York Times had an article that addressed the lack of accountability for generic drug manufacturers.
The U.S. Supreme Court held that generic drug suppliers don’t have the same disclosure and warning requirements that brand name drugs have. So, be careful when taking generic medications. The medication will be the same, but the labels and warnings will not. You should do your own research into the particular medication that you are taking.
Also, some legislators in North Carolina appear to be trying to provide immunity for drug companies for drugs that were FDA-approved. Based on failures by the FDA in the past, this would be very dangerous for NC consumers. Here is a response to this bill: